Search results
Dave Mehalick. Chairman, President and Chief Executive Officer. Mr. Mehalick is a successful executive with a career spanning over 30 years across a variety of industries including life sciences, technology, financial services, military contracting, entertainment, and consumer products. READ MORE.
View Dave Mehalick’s profile on LinkedIn, a professional community of 1 billion members. Experience: Coeptis Therapeutics · Education: University of Pittsburgh · Location: Greater Pittsburgh...
- 500+
- 4.3K
- Coeptis Therapeutics
- Wexford, Pennsylvania
David Mehalick is Chairman/President/CEO/Co-Founder at Coeptis Therapeutics Inc. See David Mehalick's compensation, career history, education, & memberships.
- Chairman/President/CEO/Co-Founder
- Coeptis Therapeutics Inc
Jan 4, 2024 · WEXFORD, Pa., Jan. 4, 2024 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company developing innovative cell therapy platforms...
Apr 30, 2024 · April 30, 2024 — In a recent interview with InvestorNews, Dave Mehalick, Chairman, President, and CEO of Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP), ...
- 8 min
- 4.1K
- InvestorCoffee
Mar 4, 2024 · In an insightful interview with Tracy Weslosky, Dave Mehalick, Chairman, President, and CEO of Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP), delves into the company’s groundbreaking work in cell therapy, particularly against the backdrop of the “tripledemic” of influenza, COVID-19, and respiratory syncytial virus (RSV).
Apr 30, 2024 · April 30, 2024 — In a recent interview with InvestorNews, Dave Mehalick, Chairman, President, and CEO of Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP), discussed the company’s innovative approaches in cell therapy, highlighting their focus on making such treatments more universally accessible. Mehalick explained, “What we are working ...
